PatientSafe plans to use the funds to further scale operations, accelerate sales and customer success, and drive further innovation in clinical communications and care delivery.
The round was led by HighBar Partners with participation from existing investors Merck Global Health Innovation Fund, Camden Partners, Psilos Group, and TPG. The investors share PatientSafe’s vision of a simple and effective care experience enabled by an outcome-driven, mobile-enabled platform at the point-of-care.
“The success of PatientSafe highlights the value that an enterprise-grade clinical workflow and communication platform brings to its customers by improving clinician satisfaction, care team productivity, and patient safety in the post-EMR era,” said John Kim, Co-founder and Managing Partner of HighBar Partners. “We are excited to partner with the PatientSafe team to expand go-to-market capabilities, identify product acquisition opportunities, and continue to foster long-term relationships with leading healthcare organizations throughout the country and internationally.”
Founded in 2002, PatientSafe focuses on empowering care teams to communicate and work together reliably and efficiently through its PatientTouch® platform. PatientTouch is the only mobile platform that unifies clinical communications with critical workflows in a single application for more than 80 leading healthcare institutions.
